Kringle Pharma, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Toyonaka Japan (2001)

Organization Overview

First Clinical Trial
2008
NCT00797706
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kringle Pharma Europe AB | Kringle Pharma, Inc.